[HTML][HTML] Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
Clinical Microbiology and Infection, 2020 - Elsevier
Abstract Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral …
[HTML][HTML] Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N Lian, H Xie, S Lin, J Huang, J Zhao… - Clinical Microbiology and …, 2020 - ncbi.nlm.nih.gov
Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N Lian, H Xie, S Lin, J Huang… - … and infection: the …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
N Lian, H Xie, S Lin, J Huang, J Zhao… - Clinical Microbiology and …, 2020 - europepmc.org
Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
[HTML][HTML] Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N Lian, H Xie, S Lin, J Huang… - Clinical …, 2020 - clinicalmicrobiologyandinfection …
Abstract Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral …
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
N Lian, H Xie, S Lin, J Huang, J Zhao, Q Lin - 2020 - cabidigitallibrary.org
Abstract Objectives: Coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral …
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
N Lian, H Xie, S Lin, J Huang, J Zhao… - Clinical Microbiology and …, 2020 - europepmc.org
Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …
syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being …